Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.80831 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.70848 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.79215 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.76081 | 36 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.77559 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.81844 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.83187 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.78737 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.77972 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.77516 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.78023 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.7749 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.78687 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78539 | 35 |